Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for ABEO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 146.83M
March 31, 2026 168.27M
December 31, 2025 191.40M
September 30, 2025 207.46M
June 30, 2025 225.86M
March 31, 2025 84.49M
December 31, 2024 98.06M
September 30, 2024 110.04M
June 30, 2024 123.05M
March 31, 2024 62.68M
December 31, 2023 52.56M
September 30, 2023 54.09M
June 30, 2023 37.11M
March 31, 2023 40.70M
December 31, 2022 52.49M
September 30, 2022 23.50M
June 30, 2022 25.99M
March 31, 2022 37.21M
December 31, 2021 50.02M
September 30, 2021 67.00M
June 30, 2021 77.56M
March 31, 2021 86.77M
December 31, 2020 95.03M
September 30, 2020 96.87M
June 30, 2020 107.88M
Date Value
March 31, 2020 116.04M
December 31, 2019 129.26M
September 30, 2019 47.92M
June 30, 2019 62.51M
March 31, 2019 68.31M
December 31, 2018
September 30, 2018 112.22M
June 30, 2018 119.84M
March 31, 2018 132.00M
December 31, 2017 137.75M
September 30, 2017 56.52M
June 30, 2017 58.30M
March 31, 2017 63.21M
December 31, 2016 69.14M
September 30, 2016 31.18M
June 30, 2016 34.30M
March 31, 2016 37.40M
December 31, 2015 40.14M
September 30, 2015 43.28M
June 30, 2015 30.41M
March 31, 2015 7.948M
December 31, 2014 11.52M
September 30, 2014 0.165M
June 30, 2014 0.055M
March 31, 2014 0.299M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Forum Markets, Inc. 4.102M
Corcept Therapeutics, Inc. 308.20M
ACADIA Pharmaceuticals, Inc. 956.47M
Alnylam Pharmaceuticals, Inc. 3.308B
Anika Therapeutics, Inc. 38.41M